This is a public procurement framework agreement for specialist medical services, divided into 18 lots, for a duration of 18 months. Each service is considered a separate lot, allowing economic operators to participate without restrictions and without the need to form partnerships. Each bidder may s
Tender closed on 28 Jul 2025. Awaiting award.
This is a public procurement framework agreement for various medicines, divided into 83 lots, intended for a duration of 36 months. Suppliers are invited to submit their offers based on the specifications outlined in the tender documents. Note: According to the provisions of O.U.G. 107/2017, the con
This contract involves a public procurement framework for various medicines, divided into 59 lots, for a duration of 36 months. Suppliers are invited to submit their offers in accordance with the specifications outlined in the tender documents. Please note that, as per the provisions of O.U.G. 107/2
This public procurement framework agreement is for laboratory reagents and consumables, divided into 22 lots, for a duration of 24 months. Suppliers are required to refer to the specifications document and its annex for detailed requirements. Note: According to the provisions of O.U.G. 107/2017, the
This public procurement contract involves the supply of medical equipment, specifically electrocardiography devices, divided into 6 lots. The contract is valid until December 31, 2025, and is governed by the specifications outlined in the tender documents. Suppliers are encouraged to submit their bi
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
